Invention Grant
US08821873B2 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
有权
用抗CD20抗体治疗弥漫性大细胞淋巴瘤
- Patent Title: Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
- Patent Title (中): 用抗CD20抗体治疗弥漫性大细胞淋巴瘤
-
Application No.: US14045375Application Date: 2013-10-03
-
Publication No.: US08821873B2Publication Date: 2014-09-02
- Inventor: Christine A. White , Antonio J. Grillo-Lopez
- Applicant: Biogen Idec Inc.
- Applicant Address: US MA Weston
- Assignee: Biogen Idec Inc.
- Current Assignee: Biogen Idec Inc.
- Current Assignee Address: US MA Weston
- Agency: Arnold & Porter LLP
- Agent Wendy Lee; Ginger R. Dreger
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/475 ; A61K31/675 ; A61K35/28 ; C07K16/28 ; A61K31/704 ; A61K31/573 ; C07K14/725 ; A61K39/00
Abstract:
The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
Public/Granted literature
- US20140030263A1 TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY Public/Granted day:2014-01-30
Information query
